Earum Pharmaceuticals Rights Issue 2023 vs Libas Consumer Products Rights Issue 2022

Comparison between Earum Pharmaceuticals Rights Issue 2023 and Libas Consumer Products Rights Issue 2022.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Earum Pharmaceuticals Rights Issue 2023 and Libas Consumer Products Rights Issue 2022. Earum Pharmaceuticals Rights Issue 2023 is listed on BSE while Libas Consumer Products Rights Issue 2022 is listed on NSE.

 Earum Pharmaceuticals LimitedLibas Consumer Products Limited
LogoEarum Pharmaceuticals Rights Issue 2023 LogoLibas Consumer Products Rights Issue 2022 Logo
Listing AtBSENSE
Terms of PaymentPartial - ₹0.50 on Application
Entitlement4 Equity Shares for every 1 Equity Shares held on the Record Date1 Equity Shares for every 2 Equity Shares held on the Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarBigshare Services Pvt.Ltd.Bigshare Services Pvt.Ltd.
Lead ManagersAxis Bank Ltd.Sarthi Capital Advisors Pvt.Ltd.

Rights Issue Size and Price

The issue size of Earum Pharmaceuticals Rights Issue 2023 rights issue is ₹49.34 Crores, whereas Libas Consumer Products Rights Issue 2022 rights issue size is ₹18.52 Crores.

 Earum Pharmaceuticals LimitedLibas Consumer Products Limited
Issue Size24,67,16,400 shares88,20,000 shares
Issue Size (Amount)₹49.34 Crores₹18.52 Crores
Issue Price₹2 per share₹21 per share
Face Value₹2 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Earum Pharmaceuticals Rights Issue 2023 is Apr 10, 2023 while record date of Libas Consumer Products Rights Issue 2022 is Sep 16, 2022.

 Earum Pharmaceuticals LimitedLibas Consumer Products Limited
Record DateApr 10, 2023Sep 16, 2022
Credit of Rights EntitlementsApr 26, 2023Sep 26, 2022
Bid/Offer Opens OnMay 02, 2023Sep 27, 2022
Renunciation of Rights EntitlementsMay 26, 2023Oct 03, 2022
Bid/Offer Closes OnMay 31, 2023Oct 07, 2022
Deemed Date of AllotmentJun 20, 2023Oct 18, 2022
Credit DateJun 21, 2023Oct 20, 2022
Listing DateJun 26, 2023Oct 25, 2022

Financials details

Comparison of Earum Pharmaceuticals Rights Issue 2023 and Libas Consumer Products Rights Issue 2022 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Earum Pharmaceuticals LimitedLibas Consumer Products Limited
Financial
Earum Pharmaceuticals Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxReserves and Surplus
31-Mar-2036.1657.381.828.25
31-Mar-2127.8750.020.098.33
31-Mar-2228.7928.742.224.39
Amount in ₹ Crore
Libas Consumer Products Limited Financial Information (Restated)
Period EndedTotal RevenueProfit After Tax
31-Mar-2135.54-1.63
31-Mar-2246.722.56
Amount in ₹ Crore

Compare with others

Compare:

Earum Pharmaceuticals Rights Issue 2023 Vs Libas Consumer Products Rights Issue 2022